
Multiple myeloma: Unveiling the survival data with different lines of treatments
Author(s) -
Suja Abraham,
Helan Kurian,
Arpith Antony,
JeevaAnn Jiju,
Timy Thomas
Publication year - 2022
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_1426_21
Subject(s) - medicine , retrospective cohort study , confidence interval , survival analysis , observational study , population , oncology , environmental health
The incidence of multiple myeloma (MM) is rising and there are fewer Indian studies; a comprehensive research of MM patients' survival data in a real-world population is needed. This study aims to analyze the survival status of MM patients with different treatment regimens along with its correlation to other parameters such as treatment-free interval (TFI) and time-to-next treatment (TTNT).